:

Chun-Ka Wong1, Karl Poon2, Kent Chak-Yu So3

  • 1Cardiology Division, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR; Cardiology Division, Department of Medicine, Queen Mary Hospital, Hong Kong SAR; Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

JACC. Asia
|January 7, 2026
PubMed
概括

通过导管电术,使用像BASILICA和LAMPOON这样的技术,在亚太地区越来越多地用于结构性心脏干预. 这些方法有助于预防膜植入过程中的并发症,改善患者的治疗结果.